Market sentiment signals for Summit Therapeutics (SMMT): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
25 analysts
Options Flow (P/C)
0.80
More calls — Bullish
Avg Consensus PT
$32
+106.3%
Highest Price Target
$44
+184.9%
Lowest Price Target
$12
-23.0%
Short Interest
26.3%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Barclays | Etzer Darout— | +29.5% | $18 → $20 | Maintained | Equal-Weight |
| Sep 29, 2026 | Citigroup | Yigal Nochomovitz— | +178.4% | $40 → $43 | Maintained | Buy |
